FDA Lists Poor Conditions At Compounding Pharmacies

Law360, New York (April 12, 2013, 8:37 PM EDT) -- Nearly all compounding pharmacies inspected by the U.S. Food and Drug Administration recently had conditions that increased the risk of drug contamination, the agency said Thursday, days before the agency commissioner's scheduled appearance before a House panel to plead for more explicit FDA authority over compounders.

FDA Commissioner Margaret Hamburg announced the findings in a blog post Thursday titled, “Proactive Inspections Further Highlight Need for New Authorities for Pharmacy Compounding.”

“There continues to be reason for concern about sterility deficiencies and other problems in some compounding...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.